Jacob Gottlieb is an entrepreneur and philanthropist. As an entrepreneur, he has founded companies such as Visium Asset Management, LLC (VAM), Balyasny Asset Management, L.P. (BAM), and Altium Capital (AC). His work as a philanthropist involved raising money for programs and organizations that would educate the youth. The names of the organizations are Robin Hood Foundation, New Yorkers for Children, The Windward School, and the East Harlem Tutorial Program. AC is the investment fund that Gottlieb created most recently.
AC invest in growing companies that exist in the healthcare sector. Some of the first companies that AC chose to make investments are Oramed Pharmaceuticals (ORMP) and Amarin Corporation (AMRN), and Oragenics. AC made 5.6 percent investment stake in ORMP. ORMP has developed an oral medication delivery system used to help diabetics receive drugs that normally would be injected. It improves the method of how insulin is administered and makes medicine more affordable for people. The pill will help millions of people. AMRN is a company with headquarters in Dublin, Ireland, and the company develops drugs that help cardiovascular health. Oragenics works in replacement therapy. Harmful bacteria are replaced by good bacteria. Oragenics develops new technology along with some antibiotics to fight infectious disease. Most of their work focuses on throat and esophagus.
Gottlieb helped VAM become a nearly $8 billion hedge fund. It would be in 2016 while in VAM that the fund would go through insider-trading scandal. Gottlieb was able to avoid scandal. While working at BAM, he was considered to be a top earner. It would be at Merlin BioMed Group that Gottlieb would work as a portfolio manager. Gottlieb earned a degree in Economics from Brown University. He also distinguished as a Chief Financial Analyst in 2001. He gained experience analyzing healthcare field while working as a buy-side analyst at Sanford C. Bernstein & Co., LLC.